News
- Risk of blood clots remains for almost a year after COVID-19 infection, study suggests 20 September 2022 COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.
- Bristol academics conferred as Fellows of the Academy of Social Sciences 2 September 2022 Two University of Bristol academics have been conferred as Fellows of the Academy of Social Sciences.
- Increase in non-COVID-19 respiratory infections predicted this winter 9 August 2022 An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists. The warning comes following the results of a new study, published in The Lancet Regional Health – Europe, which found that over 55% of respiratory disease hospitalisations during the pandemic’s peak were caused by non-SARS-CoV-2 infections.
- New DNA repair-kit successfully fixes hereditary disease in patient-derived cells 29 July 2022 Genetic mutations which cause a debilitating hereditary kidney disease affecting children and young adults have been fixed in patient-derived kidney cells using a potentially game-changing DNA repair-kit. The advance, developed by University of Bristol scientists, is published in Nucleic Acids Research.
- Feeding dogs raw meat associated with increased presence of antibiotic-resistant bacteria 21 July 2022 New research has revealed an association between the feeding of raw meat to pet dogs and the presence of bacteria resistant to critically important antibiotics.
- New animations report the views of young people using flash glucose monitoring for type 1 diabetes 21 July 2022 Two new animations from the NIHR Biomedical Research Centre (BRC) report the views and experiences of young people (from 8 to 17 years old) using flash monitoring for type 1 diabetes.
- Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds 20 July 2022 Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.
- New report finds stark impact of newborn illness on mortality throughout childhood 14 July 2022 New evidence has found a link between poor health as a newborn and mortality up to the age of ten. The new report from England’s National Child Mortality Database (NCMD), led by the University of Bristol, shows of the 4,829 children aged ten and under who died in England between 2019 and 2021, 72 per cent were found to have required additional care in the neonatal period.
- People from low socioeconomic backgrounds could reduce chronic kidney disease risk with regular exercise, study suggests 12 July 2022 New research has found people from lower socioeconomic backgrounds who regularly exercise could substantially reduce their risk of chronic kidney disease. Chronic kidney disease is linked to poor quality of life and an increased risk of death. Its treatment is also associated with high healthcare costs, with diabetes and high blood pressure major factors that contribute to the disease.
- Bristol’s Children of the 90s study helps scientists pinpoint those most at risk of Long COVID 30 June 2022 Bristol-based study Children of the 90s has helped improve understanding of the causes and treatment of long COVID.
Infection and immunity press releases
Press releases relating to infection and immunity on the University's central news pages.